Eugenics Revisited: Author Asks if We're Ready for Genetically Modified Humans
By Howard Lovy,
Foreword Reviews
| 03. 24. 2016
Untitled Document
If you think the argument over the benefits and risks of genetically modified foods is confusing and contentious, just wait until the debate over genetically modified people gets into full swing. All the elements are there: the potential to do great good through the eradication of disease and great harm through accidental or weaponized genetic destruction, not to mention the morally gray areas of so-called “designer babies” and corporate control over life-enhancing technologies.
The technology is almost here, and thinking ahead for us are authors like Paul Knoepfler, whose book GMO Sapiens: The Life-Changing Science of Designer Babies, an INDIEFAB finalist, tackles these tough issues and more. I was curious about what to expect from the next contentious public debate over science. So, I asked him.
Eugenics is forever associated with the ugly stain of Nazism and the forced sterilization of thousands in the United States. How can the idea of genetic modification of humans ever come back from that?
In researching and writing my book, I came across a wide range of opinions about human genetic...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...